- Mathalon, Daniel;
- Mathalon, DH;
- Ahn, KH;
- Perry, EB;
- Cho, HS;
- Roach, BJ;
- Blais, RK;
- Bhakta, S;
- Ranganathan, M;
- Ford, JM;
- D'Souza, DC
Background: N-methyl-d-aspartate (NMDA) receptor hypofunction has been implicated in the pathophysiology of schizophrenia and its associated neurocognitive impairments. The high rate of cigarette smoking in schizophrenia raises questions about how nicotine
